Remove 2022 Remove Hospice Remove In-home health Remove Personal care
article thumbnail

How Home Health, Personal Care Reimbursement Guiding Addus’ M&A Strategy

Hospice News

As Addus HomeCare Corporation (NASDAQ: ADUS) sinks teeth into acquisitions, the company will be taking smaller bites when it comes to hospice deals. Addus has indicated for roughly the last year that it will orient its M&A strategy towards its home health and personal care services, with hospice becoming less of a priority.

article thumbnail

5 Most Game-Changing Hospice Deals from 2022

Hospice News

Though hospice deal volume dipped in 2022 compared to previous years, five particular transactions could paint a larger picture of where investors see value in the space. These interesting, unusual or groundbreaking deals could signal what’s to come in 2023 and help shape the hospice market’s long-term future. s (NYSE: HUM) $2.8

2022 229
professionals

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Addus Orients M&A Strategy Away From Hospice, Towards Home Health, Personal Care

Hospice News

Addus HomeCare Corporation’s (NASDAQ: ADUS) is shifting its M&A strategy away from hospice deals to focus on its home health and personal care businesses. Texas-based Addus provides personal, home health and hospice care across 207 locations in 22 states, reaching roughly 46,500 patients annually.

article thumbnail

Aveanna Healthcare’s ‘Strong, Disciplined’ Hospice Growth

Hospice News

Though hospice is a smaller segment for Aveanna Healthcare Holdings Inc. Aveanna’s home health and hospice segment has had mixed results thus far this year, but saw recent improvement, along with its other service lines, last quarter. It provides home health, hospice, private duty and personal care.

Hospice 237
article thumbnail

Hospice M&A Takes Downturn in Early 2023, May Rebound in Second Half of the Year

Hospice News

Hospice merger and acquisition activity has taken a downturn in 2023, which is in line with projections from M&A experts. Approximately 14 hospice, home care and home health transactions were reported during the first quarter of 2023, according to recent data from Mertz Taggart.

2023 194
article thumbnail

New Leadership at Interim HealthCare; Former Amedisys CEO to Lead TheKey

Hospice News

Paul Mastrapa, former CEO of Help at Home, will succeed her. The Florida-based company is a home-based care franchise that provides home health care, hospice care, palliative care, pediatric care and personal care to about 200,000 patients annually from more than 330 U.S.

article thumbnail

Fortis Health, Grant Avenue Capital ‘Intensely Focused’ on Hospice Expansion

Hospice News

Home-based care veteran Rob Radics took the helm as CEO of Fortis Home Health & Hospice in May, and in the early days of his tenure is laser-focused on hospice growth. Most recently, he served as the president of the home health and hospice segments at Aveanna Healthcare Holdings (NASDAQ: AVAH).

Hospice 219